Selection of Exchange Students Sample Clauses

Selection of Exchange Students. 10.1 Each institution will inform the other of its exchange application procedures and deadlines in good time each year. Each institution agrees to abide by the other’s procedures and deadlines.
AutoNDA by SimpleDocs
Selection of Exchange Students. 2.1. The home university shall recommend students for participation in the exchange programs. Students nominated for participation in the exchange programs must have successfully completed at least one full year of academic study at their home university, with a grade point average of 3.0 on a 4.0 scale, or an equivalent level of academic achievement mutually recognized by the Parties.
Selection of Exchange Students. Prospective Exchange Students will be selected and nominated for the exchange by the candidate’s Home Institution. The Host Institution will reserve the right to make the final decision regarding the admission of each candidate nominated for the exchange. Admission for participation in the exchange does not confer the right to pursue a degree at the Host Institution.
Selection of Exchange Students. Exchange candidates will be selected on the basis of academic excellence and other criteria imposed by the Home Institution’s selection committee and will be recommended to the Host Institution. They must meet the admission requirements of the program which they plan to pursue at the Host Institution. The Host Institution retains the right to approve or reject any recommendation based on whether the candidate’s qualifications meet admission requirements at the Host Institution.
Selection of Exchange Students. The home university will normally recommend most suitable students to the host university based on language ability and academic excellence.
Selection of Exchange Students. Both parties agree that candidates to an exchange period shall be selected by the home institution. The home university will normally recommend most suitable students to the host university based on language ability and academic excellence. Selected students must follow the host university application process and provide all required documents. The host university reserves the right to accept or not selected students.
Selection of Exchange Students. Each exchange student participating in a student exchange pursuant to this Agreement will be selected by their Home Institution on the basis of an exchange student’s previous academic merit as well as an exchange student’s knowledge of the required language at the Host Institution, his or her motivation and additional qualifications. It is desirable that the relevant student already has completed four semester of law studies at the Home Institution. The host institution will reserve the right to make the final decision regarding the admission of each student nominated for the exchange. Selection for participation in the student exchange program does not confer the right to pursue a degree at the host institution. The home faculty will advise the host faculty of any course details that are part of an exchange student's curricular plan and, wherever possible and expressively permitted by the student, particulars such as known health problems which might affect the exchange student's progress, or which mean that the exchange student may require special assistance. The Host Institution will endeavor to ensure that each exchange student is admitted to courses that are part of the student’s curricular plan. However, admission by the Host Institution to a specific course is subject to the Host Faculty being satisfied that the exchange student has the necessary qualifications, experience and language proficiency for the chosen area of study and the availability of resources in the period for which admission is sought. Neither the Home Institution nor the Host Institution will, on the grounds of race, color, national origin, age, ancestry, disability or handicap, veteran status, sex, sexual preference, or creed, exclude any prospective exchange student from participation in the student exchange program set out in this Agreement.
AutoNDA by SimpleDocs
Selection of Exchange Students. At least four months prior to the start of the semester of the intended period of the exchange, each institution agrees to provide to the partner institution information about the number of students who would like to apply for participation in an exchange at the partner institution. Prior to the approval of any applicant, both institutions agree to negotiate the number of students that can be accommodated during a given semester. The current exchange balance will be taken into consideration at this time. It is agreed that both institutions will aim to fill [insert number] semester exchange placements per academic year. If the number of exchange applicants becomes imbalanced in one direction, the flow in that direction for the following academic years may be limited until the balance is obtained. The absence of exchanges during any one calendar year is possible and does not nullify this agreement. The home institution will establish and administer its own policies, and procedures for acceptance into the program, consistent with reasonable criteria (e.g. space limitations, course restrictions, academic qualifications, language proficiency). Applicants for participation in the exchange program will be nominated by the home institution. Applicants requesting admission that have not been nominated by the home institution will not be considered. The host university reserves the right to review the applications of nominees and make final decisions concerning their admission. Each institution agrees to accept applications from students from the partner institution for an exchange period of one semester or one academic year of full-time study. Students admitted for an exchange of two semesters at the host institution will count as two exchange placements. Full-time study signifies a number of academic credits taken by the exchange student at the host institution. This number of academic credits is the total that normally corresponds to full-time study at the home institution. Each institution will present applications to the partner university by a mutually agreed deadline, which will be at least three months prior to the commencement of the proposed semester of attendance. Each institution will inform the other of its final admission decision within thirty days of receipt of completed application materials. Standards and Admission Requirements Exchange students applying for the exchange program at GVSU pursuant to this Agreement must show evidence of English langu...
Selection of Exchange Students 

Related to Selection of Exchange Students

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Termination of Exchange Fund Any portion of the Exchange Fund that remains undistributed to the holders of Company Common Stock for six months after the Effective Time shall be delivered to Parent, upon demand, and any holder of Company Common Stock who has not theretofore complied with this Article II shall thereafter look only to Parent for payment of its claim for Merger Consideration.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Selection of Candidates 5.12 The Appointments Committee shall consider all candidates for a Probationary, Tenured, Limited-Term, Externally-Funded or Visiting position and shall interview all short-listed candidates who present themselves for interview.

  • Selection of Mediator A single mediator that is acceptable to both parties shall be used to mediate the dispute. The mediator will be knowledgeable in the subject matter of this Contract, if possible.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Professional Study Permanent unit members may apply for professional study leave by outlining in writing the plan that is to be followed and the institution to be attended. In addition, a clear statement must be included in the request indicating the need for educational study and the potential value to the District upon completion of such study. (See Appendix A, 4.033)

  • Patients The Dentist shall accept Covered Persons as patients as reasonably permitted by the Dentist's patient load and appointment calendar. The Dentist will provide Covered Dental Services to Covered Persons on the same basis as to the Dentist's other patients (for example: scheduling, quality of service, and fee charges). The Dentist will be solely responsible to Covered Persons for dental advice and treatment; SDC will have no control over Dentist's practice or the dentist-patient relationship.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

Time is Money Join Law Insider Premium to draft better contracts faster.